Clinical Trial: Usability and Clinical Validation of the Flu A/B/COVID-19 + RSV Multiplex Rapid Test

U.S., Oct. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07875270) titled 'Usability and Clinical Validation of the Flu A/B/COVID-19 + RSV Multiplex Rapid Test' on Oct. 08.

Brief Summary: This will be a prospective study for the clinical validation of the CorDx Tyfast Flu A/B/COVID-19 + RSV Multiplex Rapid Test for the qualitative detection and differentiation of SARS-CoV-2, Influenza A, Influenza B and RSV in AN samples. Results from the CorDx Tyfast Flu A/B/COVID-19 + RSV Multiplex Rapid Test will be compared to results from a 510(k) cleared highly sensitive, multi-analyte reverse transcriptase polymerase chain reaction (RT-PCR) test for SARS-CoV-2, Influenza A, Influenza B and RSV, such as the 510(k) cl...